who owns the patent for retatrutide Pharma Competitive Intelligence in One Session: CT-388 and GLP-1/GIP Obesity Landscape Retatrutide, an experimental weight-loss drug,
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

























